Hypercortisolism News Today

Christopher Lucci, MD, reviews the current diagnostic tests for hypercortisolism, which include the Dexamethasone Suppression Test, DHEA level tests, and ACTH assessments.

The panel emphasizes the importance of early identification of patients based on subgroups, such as those with difficult-to-control diabetes, hypertension, and bone issues, highlighting that the inability to lower a patient's insulin dosage is a significant risk factor for hypercortisolism.

The findings suggested the need for closer postsurgical monitoring of patients with a family history of autoimmune disease.

The drug, which inhibits cortisol synthesis, is seen as addressing an unmet need.